Table 2.
miRNA transcripts displaying a significant differential expression in patients with lung cancer compared to control patients.
| ID | logFC | P-Value | adj.P-Va |
|---|---|---|---|
| hsa-miR-150-5p_477918_mir | 3,65 | 1,87E-03 | 3,91E-02 |
| hsa-miR-144-5p_477914_mir | −11,37 | 3,76E-04 | 1,28E-02 |
| hsa-miR-1-3p_477820_mir | −13,78 | 1,41E-06 | 1,92E-04 |
| hsa-miR-584-5p_478167_mir | −9,55 | 1,90E-08 | 5,17E-06 |
| hsa-miR-133b_480871_mir | −7,72 | 1,30E-03 | 3,52E-02 |
| hsa-miR-451a_478107_mir | −3,29 | 3,50E-04 | 1,28E-02 |
| hsa-miR-27a-5p_477998_mir | 4,93 | 8,05E-05 | 7,30E-03 |
| hsa-miR-21-3p_477973_mir | 5,65 | 1,99E-04 | 1,28E-02 |
| hsa-miR-199a-5p_478231_mir | −7,73 | 3,47E-04 | 1,28E-02 |
| hsa-miR-1249-3p_478654_mir | 6,70 | 5,62E-04 | 1,70E-02 |
| hsa-miR-485-3p_478125_mir | 4,80 | 1,82E-03 | 3,91E-02 |
| hsa-miR-20b-5p_477804_mir | −8,18 | 3,05E-04 | 1,28E-02 |
| hsa-miR-181c-5p_477934_mir | −3,79 | 2,06E-03 | 4,01E-02 |
| hsa-miR-30e-5p_479235_mir | −6,46 | 1,45E-03 | 3,59E-02 |
Log fold-change expression, p-value and adjusted p-value of the 14 miRNAs significantly dysregulated in EVs from the pleural lavage of lung cancer patients compared to control (adj. p-value < 0.05 and logFC lower or higher than 3).